Published in J Hyg (Lond) on September 01, 1972
Skin tests with influenza virus. J Hyg (Lond) (1973) 1.22
Comparative trials of live attenuated and detergent split influenza virus vaccines. J Hyg (Lond) (1975) 1.22
Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection. J Hyg (Lond) (1985) 1.07
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. J Hyg (Lond) (1983) 1.07
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. J Hyg (Lond) (1983) 1.06
Kinetics of specific in vitro antibody production following influenza immunization. Clin Exp Immunol (1982) 1.05
Regional T- and B-cell responses in influenza-infected ferrets. Infect Immun (1978) 0.93
Immune response to vaccination with a live influenza virus (H3N2) vaccine ("Ann" strain). Infect Immun (1973) 0.91
Immunization of ferrets against influenza: a comparison of killed ferret grown and egg grown virus. Br J Exp Pathol (1974) 0.89
Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines. Infect Immun (1974) 0.86
Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection. Postgrad Med J (1973) 0.86
Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique. Clin Exp Immunol (1975) 0.85
Placebo-controlled double-blind clinical studies on the efficacy of different influenza vaccines assessed by experimental and natural infection. Postgrad Med J (1976) 0.80
Neutralizing activity in the gastrointestinal contents of piglets vaccinated with an ethylenimine-inactivated porcine enterovirus. Can J Comp Med (1977) 0.80
Assessment of vaccine efficacy by challenge studies in man. Postgrad Med J (1976) 0.80
The administration of drugs and vaccines by the intranasal route. Br J Clin Pharmacol (1976) 0.78
Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers. J Hyg (Lond) (1979) 0.78
Editorial: Vaccines against influenza. Br Med J (1974) 0.75
Comparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection. J Hyg (Lond) (1979) 0.75
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) (1969) 2.12
Attenuation of human influenza A viruses. Br Med J (1969) 1.90
Neuraminidase- and hemagglutinin-inhibiting antibodies in serum and nasal secretions of volunteers immunized with attenuated and inactivated influenza B-Eng-13-65 virus vaccines. J Immunol (1970) 1.84
Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29
Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child (1995) 12.65
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess (1999) 8.63
The European Community Respiratory Health Survey. Eur Respir J (1994) 7.87
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
The language of health. BMJ (1993) 6.16
Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ (1990) 6.08
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Screening for hypertension: some epidemiological observations. Br Med J (1974) 4.22
Association of respiratory symptoms and lung function in young adults with use of domestic gas appliances. Lancet (1996) 4.09
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Work of a district ethical committee. Br Med J (1979) 3.64
ACORN group, social class, and child health. J Epidemiol Community Health (1983) 3.27
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol (1991) 2.90
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
National Study of Health and Growth: social and biological factors associated with height of children from ethnic groups living in England. Ann Hum Biol (1987) 2.66
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed) (1984) 2.64
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. Am J Epidemiol (1999) 2.53
Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ (1999) 2.48
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46
Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. BMJ (1993) 2.44
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J (2001) 2.35
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet (1979) 2.31
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Relation between all cause standardised mortality ratios and two indices of deprivation at regional and district level in England. J Epidemiol Community Health (1989) 2.26
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Disturbed sleep: effects of sociocultural factors and illness. Arch Dis Child (1998) 2.23
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol (1972) 2.17
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) (1969) 2.12
Nipah virus: vaccination and passive protection studies in a hamster model. J Virol (2004) 2.09
Transcription signals in embryonic Xenopus laevis U1 RNA genes. EMBO J (1985) 2.07
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Coronaviridae: second report. Intervirology (1978) 2.05
The secular trend in the height of primary school children in England and Scotland from 1972-1980. Ann Hum Biol (1984) 2.05
What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol (1989) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01
Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses. J Gen Virol (1969) 2.01
Parental smoking in childhood and adult obstructive lung disease: results from the European Community Respiratory Health Survey. Thorax (2004) 1.99
Association between obesity and asthma in 4-11 year old children in the UK. Thorax (2001) 1.99
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
An antigenic variant of the Hong Kong-68 influenza A 2 virus. J Hyg (Lond) (1971) 1.95
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90
Overweight and obesity trends from 1974 to 2003 in English children: what is the role of socioeconomic factors? Arch Dis Child (2005) 1.89
Leucine zipper motif extends. Nature (1989) 1.88
Serological epidemiological studies with influenza A viruses. J Hyg (Lond) (1965) 1.86
Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
The relation between respiratory illness in primary schoolchildren and the use of gas for cooking--I. Results from a national survey. Int J Epidemiol (1979) 1.84
Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis (2003) 1.83
Response to venepuncture for monitoring in primary schools. Arch Dis Child (1994) 1.82
Immunological relationships between the neuraminidases of human and animal influenza viruses. Bull World Health Organ (1969) 1.82